Neovasc Reducer for refractory angina relief is recognized by ESC

Reducer is the only non-pharmaceutical treatment included in the “Major New Recommendations” section of the 2019 ESC Clinical Practice Guidelines.

Share
Tendyne TMVR: One Year Predictors of Therapeutic Benefit

Which patients will benefit from transcatheter valve replacement? A recent article reveals a solution for a therapeutic gap in this population.

Share
Ancora Heart Enrolls First Patient in European Trial of AccuCinch Therapy

CorCinch-EU Study will evaluate percutaneous therapy designed to improve left ventricular function for patients with systolic heart failure.

Share
New MDCG Guidances Published on PRRC and Implant Cards

The Medical Device Coordination Group (MDCG) is working to develop guidance to ensure clarity and harmonized implementation of the new medical device regulations.

Share
Meditrial Announces The Opening of a New Office in Berlin

Meditrial announced the opening of a new office in Berlin. A single location for the support and development of clinical trials...

Share
New Transcatheter Therapy to Reshape the Failing Heart

Ancora Heart, Inc. announced the first patient was enrolled in a U.S. Early Feasibility study of First-of-Its-Kind Investigational Heart Failure Therapy.

Share
AATS Quality Assessment Program for the 21st Century

AATS has announced the launch of a new live, dynamic, interactive technology data platform to generate innovative real time analyses.

Share
Brain Stimulation to Fight Obesity: Breakthrough Findings

Published in DOM the first randomized study of Deep Transcranial Magnetic Stimulation for the treatment of obesity.

Share
Tricuspid Trends: ViV Live Case

LIVE demonstration from the Groote Schuur Hospital, Cape Town - South Africa. OPERATORS: Dr Azeem Latib and Dr Didier Tchétché.

Share